RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:352577

Bainbridge-Ropers syndrome

low confidenceDisorder

Also known as: Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome

Publications

811

Trials

1

Interventional, condition-specific

Researchers

1,443

Distinct authors in sample

Gene link

ASXL3

Definitive

Readiness

4/6

Stages with a signal

Clinical definition (Orphanet)

A rare, genetic, syndromic disorder with a variable phenotypic presentation typically characterized by microcephaly, severe feeding difficulties, , severe global development delay that frequently results in absent/poor speech, moderate to severe and . Distinctive craniofacial features include prominent forehead, high-arched, thin eyebrows, hypertelorism, downslanting palpebral fissures, long, tubular nose with broad tip and prominent nasal bridge and wide mouth with full, everted lower lip. Joint laxity and ulnar deviation of wrists are also frequently observed.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (3)

ASXL3-Related Disorder · Bainbridge-Roppers syndrome · severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

4/6 stages with a signal

An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.

  1. Gene identifiedPresent

    Definitive — ASXL3

  2. LiteraturePresent

    811 matched papers (691 in last 10 years) Source

  3. Phenotype characterisedPresent

    129 HPO annotations (e.g. Abnormal speech pattern; Everted lower lip vermilion; Dolichocephaly) Source

  4. Animal modelNot found

    No Alliance genotype “model of” associations via Monarch for these Mondo IDs

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialPresent

    1 matched on ClinicalTrials.gov

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Yes — we know a specific gene responsible (ASXL3).

GenCC classification: Definitive.

Phenotypes (Monarch / HPO)

129

Associated phenotypes · MONDO:0014205

  • Abnormal speech pattern
  • Everted lower lip vermilion
  • Dolichocephaly
  • Bulbous nose
  • Underdeveloped nasal alae

Showing 5 of 129 — open Monarch for the full list.

Animal models (Monarch / Alliance)

None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

811

811 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

811 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

691 in the last 10 years · low confidence

Phrase hits: 177 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,443

Distinct author names in 177 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Balasubramanian M11 papers · 2026

    Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.

    Papers in Europe PMC
  2. 02
    Wang L7 papers · 2025

    BGI-Wuhan Clinical Laboratory, BGI-Shenzhen, 430074, Wuhan, China.

    Papers in Europe PMC
  3. 03
    Woods E6 papers · 2026

    Division of Clinical Medicine, University of Sheffield, Sheffield, UK.

    Papers in Europe PMC
  4. 04
    Liu Y5 papers · 2023

    Department of Genetics, Jiangxi Maternal and Child Health Hospital, 330006, Nanchang, China.

    Papers in Europe PMC
  5. 05
    Wang Y5 papers · 2025

    Genetics Branch, Center for Cancer Research, NCI, Rockville, Maryland.

    Papers in Europe PMC
  6. 06
    Jiang Y4 papers · 2026

    Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas.

    Papers in Europe PMC
  7. 07
    Ockeloen CW4 papers · 2026

    Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

    Papers in Europe PMC
  8. 08
    Russell BE4 papers · 2026

    Division of Genetics, Department of Pediatrics, UCLA, Los Angeles, California, USA.

    Papers in Europe PMC
  9. 09
    Schoch K4 papers · 2021

    Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.

    Papers in Europe PMC
  10. 10
    Shashi V4 papers · 2021

    Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

1

interventional trials for this specific condition

1 interventional trial matched this specific condition name; none in our sample are currently recruiting.

Data as of 11 September 2026 · last trial check 28 July 2026

1 interventional trial — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 80.1th percentile).

low confidence · 80.1th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

1 interventional trials matched after quoted-phrase search and title/condition post-filter.

No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.

Observational and natural-history studies

1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.

Recruiting or not-yet-recruiting

Open the complete matched search on ClinicalTrials.gov

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Bainbridge-Ropers syndrome — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

("Bainbridge-Ropers syndrome" OR "Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome" OR "ASXL3-Related Disorder" OR "Bainbridge-Roppers syndrome") OR ("ASXL3" OR "ASXL3 syndrome" OR "ASXL3-related")

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Bainbridge-Ropers syndrome" OR "Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome" OR "ASXL3-Related Disorder" OR "Bainbridge-Roppers syndrome"

Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 1 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (811) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity

Ingested 2026-07-27T14:13:46.160Z